It’s just math, but here’s possible scenarios:
5% avg yield and you want annually:
$7,500 in dividends you need ~$150k
$25,000 in dividends you need ~$500k
$50,000 in dividends you need ~$1.0M
$85,000 in dividends you need ~$1.7M
6% avg yield and you want annually:
$9,000 in dividends you need ~$150k
$30,000 in dividends you need ~$500k
$60,000 in dividends you need ~$1.0M
$100,000 in dividends you need ~$1.7M
What are you going to do?💃
@CancerFinalGirl Cancer camaraderie is the best. Only one cancer patient can relate to another cancer. Patient on a deeper more spiritual level. GBM 10/2022
@hkuppy@AmericanExpress They raised their annual fee and no one complains so they decided it was best to experiment with cutting the quality of the lounges to maximize the increase in revenue, and maximize profitability from reduced costs. Happy to be a shareholder & not a centurion card holder anymore.
@Deb_Veik@22NamB Having no symptoms is frustrating but great. I had no symptoms leading up to a seizure out of the blue. I am told the prognosis is better than if you’ve been having headaches or balanced issues for months before surgery. Praying for you and your family on your journey.
@cancerscnews@harvardmed@WeizmannScience My GBM is a mesenchymal subtype and I’m doing T cell treatment. What does that his news mean in layman’s terms? Is T cell treatment for this sub type more or less effective?
@EndBrainCancer Approval would be incredible, but we’ve been teased with approval information for many years. I would be behind anything that would help DC Vax gain approval in the United States.
@AlMusella Statistics on GBM are clear and consistent. The placebo arm in the first 2 phases seem to be a real disadvantage to entering a clinical trial. Without a placebo arm some patients could potentially benefit from the new unknown treatment. Adjustments could be made in later phases